Related Articles
Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)
Latest evidence on immunotherapy for cholangiocarcinoma (Review)